Updates are available Correction dated 2026-05-21

Article History

Received: 1 November 2025

Revised: 19 February 2026

Accepted: 19 March 2026

First Online: 21 April 2026

Change Date: 14 May 2026

Change Type: Update

Change Details: The original online version of this article was revised: Following the publication of the original article, the authors identified an inaccuracy in the Discussion section. The phrase “In brain tumors, higher φ values have been observed compared to regular brain tissue”. has been removed, as it may be misleading. The original article has been updated. This correction does not affect the analysis, results or conclusions of the study.

Change Date: 21 May 2026

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s41747-026-00744-9

Declarations

:

: The study was approved by the institutional ethics committee (Institutional Review Board (IRB) of Charité–Universitätsmedizin Berlin; approval for healthy subjects: EA1/276/16, 13.10.2016; approval for patients with PCa and BPH: EA1/235/16, 04.08.2016). Informed consent was obtained from all participants.

: Informed consent for publication was obtained from all participants.

: BH: Reports grant from Abbott, Actelion Pharmaceuticals, Bayer Schering Pharma, Bayer Vital, BRACCO Group, Bristol-Myers Squibb, Charité Research Organisation GmbH, Deutsche Krebshilfe, Dt. Stiftung für Herzforschung, Essex Pharma, European Society of Radiology, Fibrex Medical Inc., Focused Ultrasound Surgery Foundation, Fraunhofer Gesellschaft, Guerbet, INC Research, InSightec Ltd., IPSEN Pharma, Kendle/MorphoSys AG, Lilly GmbH, Lundbeck GmbH, MeVis Medical Solutions AG, Nexus Oncology, Novartis, Parexel CRO Service, Perceptive, Pfizer GmbH, Philipps, sanofi-aventis S.A., Siemens, Spectranetics GmbH, Terumo Medical Corporation, TNS Healthcare GmbH, Toshiba, UCB Pharma, Wyneth Pharma, and Zukunftsfonds Berlin (TSB). BH is the Chief Editor of the ESR Journals. As such, he was not involved in the review and selection process for this article. The remaining authors declare that they have no competing interests related to this study.